AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Research

May 18: HIV Vaccine Awareness Day

blog.aids.gov

May 18, 2010 will mark HIV Vaccine Awareness Day (HVAD), an annual observance day that recognizes the thousands of volunteers, community leaders, health professionals, and scientists that work to develop a safe and effective preventive HIV vaccine. The National Institute of Allergy and Infectious Diseases (NIAID) – the Federal sponsor for HVAD – hopes the…

Drug Regimen with Short Pauses Controls HIV and Could Lower Costs, Toxicity

blog.aids.gov

Antiretroviral drugs for HIV infection usually are taken daily, and interrupting treatment for long periods of time has proven detrimental. However, a clinical trial in Uganda has found that pausing antiretroviral therapy (ART) for just two days every week is at least as effective as taking ART continuously over a 72-week period. In addition, the…

Putting TLC+ to the Test

Listen:

Javascript and flash are required to play this audio file.

Download MP3
Dr. Carl Dieffenbach, PhD

If we routinely test everyone for HIV and treat those who are infected, could we bring an end to the HIV/AIDS epidemic? The test and treat concept, modeled on data from South Africa by scientists at the World Health Organization, is a provocative HIV prevention strategy. According to mathematical modeling, a successfully implemented test and…

Goals of a Social Networking Symposium for NIH Staff

STEP: Staff Training in Extramural Programs

AIDS.gov note: Earlier this month, AIDS.gov presented an overview on using new and social media to approximately 400 Federal staff from the National Institutes of Health. (The session was offered both live and via webcast.) We applaud NIH’s commitment to providing ongoing educational opportunities for their staff. Megan Morena, Janice Nall, Miguel Gomez To learn…

Dr. Anthony Fauci’s Statement for National Native HIV/AIDS Awareness Day

blog.aids.gov

As we mentioned in yesterday’s blog post, this Saturday. March 20th is the fourth National Native HIV/AIDS Awareness Day. Below are excerpts from a statement by Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Disease, National Institutes of Health, on National Native HIV/AIDS Awareness Day. To read the entire statement, visit…

FDA Advises Patients and Care Providers on Drug Combination Safety Considerations

FDA

The U.S. Food and Drug Administration (FDA) is committed to keeping the public updated on advances and shifts in treatment options and methods. The FDA is reviewing data that suggest use of the HIV drug Invirase (saquinavir) in combination with Norvir (ritonavir) may have a potentially serious effect on a patient’s heart. The data, drawn…

Highlights from the 2010 Conference on Retroviral and Opportunistic Infections

Dr. Anthony Fauci

A week ago we blogged about ways to stay connected to the 17th Conference on Retroviral and Opportunistic Infections (CROI). Since then, the world’s premiere researchers and scientists have come together at the San Francisco Moscone Center to discuss advances and future directions in the prevention and treatment of HIV and AIDS. Throughout the conference…

Stay Connected to Research and Events at the 2010 CROI Conference

17th Conference on Retroviral and Opportunistic Infections (CROI)

The 17th Conference on Retroviral and Opportunistic Infections (CROI) brings together researchers from across the globe working to understand, prevent, and treat HIV/AIDS. The annual conference will be held next week (February 16-19) in San Francisco and they will be using new media to help conference participants and the general public stay connected to the…